Natural Products and Biological Activities of Plants from Genus Morus: 2011-2023-Reference-Cited by-同舟云学术

Natural Products and Biological Activities of Plants from Genus Morus: 2011-2023

Published:2023-11 Issue:28 Volume:23 Page:2640-2698
ISSN:1568-0266
Container-title:Current Topics in Medicinal Chemistry
language:en
Short-container-title:CTMC

Author:

Wang Yan-Ao¹²,Liu Chao²,Guo Xu²,Zhang Meng-Qi²,Sun Shutao²,Sun Jin-Yue²,Khan Afsar³,Liu Lu¹,Chen Ying-Ying²

Affiliation:

1. Yunnan Yunzhong Institute of Nutrition and Health, Yunnan University of Traditional Chinese Medicine, Kunming, 650500, China

2. Key Laboratory of Novel Food Resources Processing, Ministry of Agriculture and Rural Affairs/Key Laboratory of Agro-Products Processing Technology of Shandong Province/Institute of Agro-Food Science and Technology, Shandong Academy of Agricultural Sciences, 23788 Gongye North Road, Jinan, 250100, China

3. Department of Chemistry, COMSATS University Islamabad, Abbottabad Campus, Abbottabad, 22060, Pakistan

Abstract

Abstract: Species of genus Morus (family Moraceae) have been used as traditional medicinal and edible resources since ancient times. Genus Morus has been acknowledged as a promising resource for the exploration of novel compounds with various bioactivities. Phytochemical investigations of the genus have led to the discovery of more than approximately 453 natural products from 2011 to 2023, mainly including flavonoids, Diels-Alder adducts, 2-arylbenzfuran, alkaloids and stilbenes. Bioactive constituents and extracts of this genus displayed a wide range of impressive biological properties including antidiabetic, anti-inflammatory, antioxidant, anti-cancer, hepatoprotective, renoprotective, and some other activities. Herein, the research progress of this genus Morus from 2011 to 2023 on phytochemistry and pharmacology are systematically presented and discussed for the first time. This current review provides the easiest access to the information on genus Morus for readers and researchers in view of enhancing the continuity on research done on this genus.

Funder

Natural Science Foundation of Shandong, China

Innovation Ability Improvement Project for Technology- Based Small and Medium-sized Enterprises of Shandong, China

Publisher

Bentham Science Publishers Ltd.

Subject

Drug Discovery,General Medicine

Reference157 articles.

1. Flora of China 2003,5,22-26

2. National Pharmacopoeia Committee. Pharmacopoeia of the People’s Republic of China; China Medical Science and Technology Press: Beijing, 2020,310-313

3. Vijayan K.; Chauhan S.; Das N.K.; Chakraborti S.P.; Roy B.N.; Leaf yield component combining abilities in mulberry (Morus spp.). Euphytica 1997,98(1/2),47-52

4. Chan E.W.; Lye P.Y.; Wong S.K.; Phytochemistry, pharmacology, and clinical trials of Morus alba. Chin J Nat Med 2016,14(1),17-30

5. Yan J.; Ruan J.; Huang P.; Sun F.; Zheng D.; Zhang Y.; Wang T.; The structure–activity relationship review of the main bioactive constituents of Morus genus plants. J Nat Med 2020,74(2),331-340